Helle Haxgart

Keine laufenden Positionen mehr

62 Jahre

Health Technology

Ursprung des Netzwerks ersten Grades von Helle Haxgart

Einheit	Art der Einheit	Industrie
ZEALAND PHARMA A/S 6	Public Company	Pharmaceuticals: Major	6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Helle Haxgart

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
Boehringer Ingelheim GmbH Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.	Pharmaceuticals: Major	Rasmus Just	Corporate Officer/Principal
NOVO NORDISK A/S	Pharmaceuticals: Major	Kirsten Drejer	Corporate Officer/Principal
H. LUNDBECK A/S	Pharmaceuticals: Major	Eva Steiness Helle Størum	Chief Tech/Sci/R&D Officer Corporate Officer/Principal
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Pharmaceuticals: Major	Ivan M. Møller	Corporate Officer/Principal
MALIN CORPORATION PLC	Biotechnology	Kirsten Drejer	Director/Board Member
NOVARTIS AG	Pharmaceuticals: Major	Ivan M. Møller	Corporate Officer/Principal
International N&H Denmark ApS International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark	Food: Major Diversified	Kirsten Drejer	Director/Board Member
GENMAB A/S	Pharmaceuticals: Major	Eva Steiness	Chairman
PHOTOCURE ASA	Medical Specialties	Eva Steiness	Director/Board Member
BIOPORTO A/S	Medical Specialties	Kirsten Drejer	Director/Board Member
ALLIGATOR BIOSCIENCE AB	Biotechnology	Kirsten Drejer	Director/Board Member
University of Aarhus	College/University	Eva Steiness	Corporate Officer/Principal
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Pharmaceuticals: Major	Kirsten Drejer	Chairman
Technical University of Denmark	College/University	Ivan M. Møller	Graduate Degree
University of Copenhagen	College/University	Eva Steiness Kirsten Drejer Rasmus Just	Doctorate Degree Corporate Officer/Principal Doctorate Degree
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates	Helle Størum	Corporate Officer/Principal
University of Southern Denmark	College/University	Helle Størum	Masters Business Admin
Danmarks Farmaceutiske Universitet	College/University	Kirsten Drejer	Undergraduate Degree
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Pharmaceuticals: Major	Kirsten Drejer	Chief Executive Officer
DTU Systems Biology		Kirsten Drejer	Director/Board Member
SERODUS ASA	Biotechnology	Eva Steiness	Chief Executive Officer
PolyPeptide Laboratories A/S PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark.	Chemicals: Specialty	Ivan M. Møller	Corporate Officer/Principal
The Danish National Advanced Technology Foundation The Danish National Advanced Technology Foundation Financial ConglomeratesFinance The Danish National Advanced Technology Foundation promotes research and innovation by providing funds. It offers private companies and universities the funds and the framework for developing new and important technologies. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.	Financial Conglomerates	Kirsten Drejer	Director/Board Member
William Demant Fonden	Investment Trusts/Mutual Funds	Eva Steiness	Director/Board Member
Phlogo ApS Phlogo ApS Pharmaceuticals: MajorHealth Technology Part of Serodus ASA, Phlogo ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The company is based in Hellerup, Denmark. Phlogo was acquired by Serodus ASA on July 10, 2013.	Pharmaceuticals: Major	Eva Steiness	Chairman
AVT Business School A/S	College/University	Rasmus Just	Masters Business Admin
Harvard Business School	College/University	Ivan M. Møller	Masters Business Admin
CURASIGHT A/S	Medical Specialties	Kirsten Drejer	Director/Board Member
The Danish Green Growth Fund	Investment Trusts/Mutual Funds	Kirsten Drejer	Director/Board Member
Danish Medical Research Council		Eva Steiness	Corporate Officer/Principal
Antag Therapeutics ApS Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark.	Pharmaceuticals: Major	Kirsten Drejer	Chairman
Vjack Holding Ivs Vjack Holding Ivs Financial ConglomeratesFinance Vjack Holding Ivs functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark.	Financial Conglomerates	Rasmus Just	Director/Board Member
Sea Longevity ApS		Rasmus Just	Director/Board Member
Vitaminpack Ivs		Rasmus Just	Director/Board Member
ResoTher Pharma AS ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.	Pharmaceuticals: Major	Kirsten Drejer	Chairman
Lyhne & Co.		Kirsten Drejer	Director/Board Member
AMNIOTICS AB	Biotechnology	Helle Størum	Corporate Officer/Principal
Pharmacosmos A/S Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark.	Pharmaceuticals: Major	Helle Størum	Corporate Officer/Principal